WEANING FROM TRACHEOSTOMY

Sponsor
University of Milan (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05271786
Collaborator
Dejan Radovanovic (Other), Marina Gatti (Other), Michele Mondoni (Other), Stefano Centanni (Other), Frascesco Blasi (Other), Andrea Gramegna (Other), Fabiano Di Marco (Other), Stefano Aliberti (Other), Humanitas Research Hospital (Other), Ca' Granda Policlinico Milano (Other), ASST Santi Paolo e Carlo (Other), Ospedale Luigi Sacco Milano (Other), Papa Giovanni XXIII Bergamo (Other)
200
1
8
24.9

Study Details

Study Description

Brief Summary

Tracheostomy is a very common surgical procedure performed in critically ill patients on invasive mechanical ventilation, and usually performed in difficult-to-wean patients and whn prolonged mechanical ventilation is required.

Weaning from the tracheostomy cannula (i.e. decannulation) represents one of the crucial steps in the post-acute respiratory management of these patients. Tracheostomy literature mainly focuses on the timing and technique of this procedure, but there is a lack of studies about decannulation and, currently, our knowledge is primarily based on expert opinion. The COVID-19 pandemic, due to the rapid increase in the number of patients exposed to prolonged mechanical ventilation, has stressed the need for objective parameters and shared standardized protocols to perform weaning from tracheostomy.

Condition or Disease Intervention/Treatment Phase
  • Other: Decannulation

Detailed Description

The study will have two co-primary objectives:
  1. To review and compare the standard operating procedures adopted for decannulation at a multicenter level.

  2. To retrospectively validate a clinical score for weaning from trachesotomy (Quantitative-Semi Quantitative - QSQ) Secondary objectives will be: 1) to assess the presence of predictors of decannulation failure; 2) to investigate if timing of decannulation can influence the result of the tracheostomy weaning process, and 3) to possibly derive a novel clinical score and a shared protocol for decannulation.

We will retrospectively collect data from patients who underwent a tracheostomy procedure and decannulation during their hospital stay since January 2017 until November 2021.

A digital dataset will be shared with the participating centers. The following variables will be collected: age, gender, comorbidities, reason and date of tracheostomy, technique used, type of cannula, variables associated with the weaning process (timing and type of caliber reduction, tube capping, assessment of airway patency by means of fiberoptic bronchoscopy, effectiveness of cough and swallowing, type and timing of change in respiratory support), level of consciousness, vital signs, arterial blood gas analysis and blood tests before and after decannulation, failure of decannulation and related complications. The dataset will be also designed to retrospectively validate the QsQ score, which is based on two main criteria (or quantitative parameters) and eight minor criteria (or semi-quantitative parameters).

Inclusion criteria

  1. Patients >18 years old

  2. Percutaneous tracheostomy performed for any reason

  3. At least one decannulation attempt during the hospitalization period. Exclusion criteria

  4. Patients with surgical/permanent tracheostomy (e.g. neuromuscular disorders needing long-term invasive mechanical ventilation) 2. Patients that underwent elective tracheostomy due to neck masses or tumors, in view of a surgical approach 3. Patients tracheostomized more than once

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
WEANING FROM TRACHEOSTOMY: A MULTICENTER, OBSERVATIONAL REVIEW OF PROCEDURES AND PROTOCOLS AND A RESTROSPECTIVE VALIDATION OF THE QSQ SCORING SYSTEM
Anticipated Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Tracheostomized patients

Patients who underwent percutaneous tracheostomy performed for any reason

Other: Decannulation
retrospective evaluation of decannulation

Outcome Measures

Primary Outcome Measures

  1. Standard procedures of decannulation [5 years]

    To review and compare the standard operating procedures adopted for decannulation at a multicenter level.

  2. QSQ score [5 years]

    To retrospectively validate a clinical score for weaning from trachesotomy (Quantitative-Semi Quantitative - QSQ )

Secondary Outcome Measures

  1. Predictors of decannulation failure [5 years]

    Assessment of the presence of predictors of decannulation failure

  2. Time of decannulation and its influence on the weaning process [5 years]

    Investigation if timing of decannulation can influence the result of the tracheostomy weaning process

  3. Shared protocol and clinical score [5 years]

    Possible derivation of a novel clinical score and a shared protocol for decannulation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients >18 years old

  2. Percutaneous tracheostomy performed for any reason

  3. At least one decannulation attempt during the hospitalization period.

Exclusion Criteria:
  1. Patients with surgical/permanent tracheostomy (e.g. neuromuscular disorders needing long-term invasive mechanical ventilation) 2. Patients that underwent elective tracheostomy due to neck masses or tumors, in view of a surgical approach 3. Patients tracheostomized more than once

Contacts and Locations

Locations

Site City State Country Postal Code
1 L. Sacco Hospital Milan Italy 20157

Sponsors and Collaborators

  • University of Milan
  • Dejan Radovanovic
  • Marina Gatti
  • Michele Mondoni
  • Stefano Centanni
  • Frascesco Blasi
  • Andrea Gramegna
  • Fabiano Di Marco
  • Stefano Aliberti
  • Humanitas Research Hospital
  • Ca' Granda Policlinico Milano
  • ASST Santi Paolo e Carlo
  • Ospedale Luigi Sacco Milano
  • Papa Giovanni XXIII Bergamo

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pierachille Santus, MD, PhD, Professor, University of Milan
ClinicalTrials.gov Identifier:
NCT05271786
Other Study ID Numbers:
  • OR022022
First Posted:
Mar 9, 2022
Last Update Posted:
Mar 9, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Pierachille Santus, MD, PhD, Professor, University of Milan

Study Results

No Results Posted as of Mar 9, 2022